Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Boehringer Ingelheim, LEO Pharma collaborate

Boehringer Ingelheim, Cue Biopharma partner to develop next generation treatment for autoimmune, inflammatory diseases

Ruchika Sharma16 April 2025 10:30 AM IST

Boston: Boehringer Ingelheim and Cue Biopharma, Inc. have announced a strategic research collaboration and license agreement to develop and...

Bristol Myers Squibb bags European Commission approval for Opdivo combo in lung cancer treatment

Bristol Myers Squibb heart disease drug fails to meet main goals in late-stage study

Ruchika Sharma16 April 2025 9:30 AM IST

Princeton: Bristol Myers Squibb has announced the Phase 3 ODYSSEY-HCM trial evaluating Camzyos (mavacamten) for the treatment of adult...

Bristol Myers Squibb, Bain Capital form new biopharmaceutical company - NewCo

Mankind Pharma to constitute committee to evaluate ways to integrate BSV

Ruchika Sharma15 April 2025 5:17 PM IST

New Delhi: Mankind Pharma has announced that the Board of Directors of the Company at its meeting has inter-alia, considered and approved the...

Biocon appoints Ekta Agarwal as Interim Company Secretary, Compliance Officer

Biocon Biologics secures market entry date for ophthalmology drug Yesafili in US

Ruchika Sharma15 April 2025 4:18 PM IST

Additionally, Biocon Biologics secured a settlement agreement in Canada with Bayer and Regeneron Pharma for launch of YESAFILI no later than July 1,...

AstraZeneca Pharma India surrenders marketing authorisation for specific indication of Olaparib

Ruchika Sharma15 April 2025 3:46 PM IST

Bangalore: AstraZeneca Pharma India Limited has surrendered its marketing authorisation for Olaparib film-coated tablets 100mg and 150mg...

India Cuts API Imports, Disburses Rs 1,008 Cr Under PLI Schemes, Parliament Told

Delhi: Counterfeit Thrombophob Ointments worth over Rs 2.5 Lakh seized following Zydus Healthcare complaint

Ruchika Sharma15 April 2025 12:49 PM IST

New Delhi: Acting on a complaint filed by pharmaceutical major Zydus Healthcare Limited, the Drugs Control Department of the Delhi government has...

JnJ receives USFDA Approval for updated Varipulse Platform Irrigation Rate

Johnson & Johnson MedTech completes first cases with OTTAVA Robotic Surgical System

Ruchika Sharma15 April 2025 11:45 AM IST

Upon completion of the study, the company plans to submit the OTTAVA system for De Novo authorization in the United States.

"Who's going to pay price to bring back manufacturing in US", asks Biocon MD

Ruchika Sharma15 April 2025 10:30 AM IST

New Delhi: Siddharth Mittal, the CEO and Managing Director of Biocon Limited, raised a critical question on Friday, asking who would bear...

Pfizer discontinues development of danuglipron for chronic weight management

Ruchika Sharma14 April 2025 5:41 PM IST

New York: Pfizer Inc. has announced the company has discontinued the development of danuglipron (PF-06882961), an oral glucagon-like...

Multi-drug resistant infections medicine 'Zaynich' to get USFDA approval next year: Wockhardt Chairman

Ruchika Sharma14 April 2025 3:49 PM IST

Dubai: Zaynich, a multi-drug resistant infections medicine, is set to receive the US Food and Drug Administration (USFDA) approval in 2026,...

Sandoz to acquire Just-Evotec Biologics EU SAS in-house development, manufacturing capabilities in France for USD 300 million

Arthritis drug: Sandoz files US antitrust litigation against Amgen

Ruchika Sharma14 April 2025 2:30 PM IST

Sandoz is seeking an injunction to prevent Amgen from using certain patent rights to block biosimilar competition and allow Sandoz to launch Erelzi.

Sun Pharma, Zydus and Glenmark recall various products in US over manufacturing issues

Ruchika Sharma14 April 2025 1:30 PM IST

Sun Pharma, Zydus, and Glenmark are recalling various products in the US market due to manufacturing-related concerns, the US health regulator...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok